- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:54 | Guggenheim raises Target stock price target to $140 on sales momentum | ||
| 13:54 | Guggenheim raises Johnson & Johnson stock price target on Icotyde | ||
| 13:54 | Guggenheim reiterates Buy on ADP stock, cites Lyric product strength | ||
| 13:42 | Asahi Kasei completes acquisition of German biotech Aicuris | ||
| 13:42 | Biogen acquires China rights to felzartamab for up to $850M | ||
| 13:42 | Palvella to present Phase 3, Phase 2 study results at ISSVA | ||
| 13:42 | Nektar reports extended alopecia areata trial results at 52 weeks | ||
| 13:42 | Dragonfly Energy secures $3M order from Stevens Transport | ||
| 13:42 | BWX Technologies to acquire Precision Components Group | ||
| 13:42 | Nexera's KeepZone unit signs white label AI voice system deal | ||
| 13:42 | Neurogene names commercial chief, adds board member | ||
| 13:42 | WW International appoints Heather Thiltgen to board of directors | ||
| 13:42 | BriaCell presents phase 3 breast cancer quality of life data at AACR | ||
| 13:42 | Mizuho reiterates Sempra Energy stock rating after Oncor approval | ||
| 13:42 | H.C. Wainwright reiterates Emergent BioSolutions stock rating on refinancing | ||
| 13:42 | Vivos Therapeutics stock price target lowered to $2.50 by H.C. Wainwright | ||
| 13:42 | H.C. Wainwright reiterates Legend Biotech stock rating on pipeline progress | ||
| 13:42 | H.C. Wainwright reiterates Ovid Therapeutics stock rating at buy | ||
| 13:42 | Largo Resources stock price target lowered to $2.80 by H.C. Wainwright on model updates | ||
| 13:42 | William Blair initiates Cameco stock with Outperform rating | ||
| 13:42 | H.C. Wainwright reiterates MeiraGTx stock rating on gene therapy progress | ||
| 13:42 | H.C. Wainwright reiterates Cardiff Oncology stock rating at buy | ||
| 13:30 | enCore Energy names Richard Little CEO, Sheriff returns as chair | ||
| 13:30 | Monte Rosa presents preclinical data on cancer drug candidate | ||
| 13:30 | Passage Bio reports biomarker improvements in FTD trial |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.